Showing 1231-1240 of 1616 results for "".
- Microstent Reduces Post-Cataract Surgery Intraocular Pressure in Glaucoma Patientshttps://modernod.com/news/microstent-reduces-post-cataract-surgery-intraocular-pressure-in-glaucoma-patients/2477293/Microstent implantation in Schlemm’s canal reduces early postoperative IOP following cataract surgery in patients with mild or moderate glaucoma, according to findings from the HORIZON study of the Hydrus microstent, according to a Reuters
- Exonate Announces Collaboration With Janssen to Develop a New Eye Drop for the Treatment of Retinal Vascular Diseaseshttps://modernod.com/news/exonate-announces-collaboration-with-janssen-to-develop-a-new-eye-drop-for-the-treatment-of-retinal-vascular-diseases/2477223/Exonate, an early stage biotechnology company, announced that it has entered into a strategic collaboration agreement with Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson. Through the collaboration, Exonate will work with Janssen Research & Development scientists to develop an
- Glaukos Announces Global Licensing Agreement With Intratus, Maker of Noninvasive Drug Delivery Platformhttps://modernod.com/news/glaukos-announces-global-licensing-agreement-with-intratus/2476756/Glaukos announced that it has entered into a licensing agreement with privately held, early-stage life sciences company Intratus. Under terms of the deal, Intratus has granted Glaukos a global exclusive license to
- User-Friendly Visual-Acuity Chart Shows Good Agreement With Existing Chartshttps://modernod.com/news/user-friendly-visual-acuity-chart-shows-good-agreement-with-existing-charts/2476405/The Runge near-vision card is user-friendly and shows good agreement with the Early Treatment Diabetic Retinopathy Study (ETDRS) and Snellen visual-acuity charts, researchers report, according to Reuters Health. “The Runge nea
- Diopsys: Study Highlights the Important Role of PERG in Evaluation of Manifest and Suspected Glaucomahttps://modernod.com/news/diopsys-study-highlights-the-important-role-of-perg-in-evaluation-of-manifest-and-suspected-glaucoma/2480170/Pattern electroretinography (PERG) is again revealed as a powerful tool for evaluating patients with early stage glaucoma, particularly glaucoma suspects, according to a news release from Diopsys. According to the latest study published in Current Ophthalmology Reports by Porciatt
- Horizon Surgical Systems Announces World’s First Robotic Cataract Surgery Using the Polaris Platformhttps://modernod.com/news/horizon-surgical-systems-announces-worlds-first-robotic-cataract-surgery-using-the-polaris-platform/2484160/Horizon Surgical Systems announced the completion of the world’s first cataract surgery performed using its Polaris robotic platform. The milestone procedure was conducted by Uday Devgan, MD, FACS.
- CDRH Expands TAP Program to Include Ophthalmic Deviceshttps://modernod.com/news/cdrh-expands-tap-program-to-include-ophthalmic-devices/2482344/Jeff Shuren, MD, director of the FDA’s Center for Devices and Radiological Health (CDRH), announced the continued expansion of the Total Product Life Cycle (TPLC) Adv
- RetinalGeniX Technologies Acquires DNA/GPS Inc.https://modernod.com/news/retinalgenix-technologies-acquires-dnagps-inc/2480949/RetinalGeniX Technologies announced the acquisition of DNA/GPS. Terms of the deal were not disclosed. The acquisition gives RetinalGeniX the rights to the platform technology designed by Larry Perich, MD, which is designed to al
- Lighthouse Guild to Launch New Technology Center For Blind and Visually Impaired in Manhattanhttps://modernod.com/news/lighthouse-guild-to-launch-new-technology-center-in-manhattan/2480669/Lighthouse Guild is launching its new Technology Center with a special event led by Calvin Roberts, MD, and featuring demonstrations and discussion from Lighthouse Guild clients, community leaders, and vision loss experts,
- Switzerland Eye Research Institute Publishes Breakthrough Case Report Using Light Exposure and Nutraceuticals for Treating Retinal Degenerationhttps://modernod.com/news/switzerland-eye-research-institute-publishes-breakthrough-case-report-using-light-exposure-and-nutraceuticals-for-treating-retinal-degeneration/2480653/Roberto Pinelli, MD, CEO of the Switzerland Eye Research Institute, announced the publication of a breakthrough paper in Archives Italiennes de Biologie. The report can be found here: